- Condition: Herpes Zoster
Interventions: Biological: V212; Biological: Placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Herpes Zoster
Interventions: Biological: V212; Biological: Placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Herpes Zoster
Interventions: Biological: V212; Biological: Matching placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Conditions: Herpes Simplex Type Two Infection; HIV Infections
Interventions: Drug: Valacyclovir; Drug: Placebo
Sponsors: University of Toronto; University of Toronto
Completed - verified March 2012 - Condition: Kidney Transplant
Interventions: Biological: Zostavax (Live attenuated herpes zoster vaccine); Biological: Placebo vaccine
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Conditions: Rubella; Varicella; Mumps; Measles
Interventions: Biological: MeMuRu-OKA (study vac); Biological: MMR, Varicella vacc (control)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Genital Herpes
Interventions: Drug: Famciclovir; Drug: Valacyclovir; Drug: Placebo matching famciclovir; Drug: Placebo matching valacyclovir
Sponsors: Novartis; Novartis Pharmaceuticals
Completed - verified June 2011 - Condition: Herpes Simplex
Interventions: Biological: GSK208141; Biological: HavrixTM (investigational formulation); Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Condition: Herpes Simplex
Intervention: Biological: GSK208141 vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Herpes Simplex
Interventions: Drug: Acyclovir; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified October 2009 - Condition: Herpes Simplex
Interventions: Drug: Acyclovir; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified November 2009


